Monday, March 17, 2014

Jackson Lab hosting a webinar about CRISPR/Cas for mice on March 27

(Reposted from a JAX email.)

Don’t miss the special JAX WebinarTM: CRISPR/Cas Mediated Genome Engineering in Mice
Date: Thursday March 27, 2014
Time: 10am PT US/ 11am MT US / 12pm CT US / 1pm ET US

Please follow this link to register now for this complementary webinar:
  
Presenter:
Haoyi Wang, Ph.D., Adjunct Faculty, The Jackson Laboratory

Moderators:
Wenning Qin, Ph.D., Associate Director, Genetic Engineering Technologies, The Jackson Laboratory
Kathy Snow, Ph.D., Manager, Technical Information Services, The Jackson Laboratory

Webinar Description
Targeting multiple genes in one generation? Systematically modulating individual components of a system in a few years rather than decades? The promises of precise, combinatorial, efficient methods for genomic engineering are exciting. The CRISPR/Cas technology applied to mouse genetic engineering could quickly advance scientific understanding of disease mechanisms by allowing researchers to ask complex questions and find answers much faster than with traditional gene targeting approaches.

During this webinar, Dr. Haoyi Wang, one of the developers of this revolutionary technology will share how CRISPR/Cas has been used successfully in mice to generate endogenous knock-in alleles, conditional (“floxed”) mutations, as well as multiple mutations in a single generation. Join us for this presentation as we discuss the following topics:
·         How CRISPR/Cas9 works to modify host genomes
·         How this technology compares to similar technologies
·         Ways in which CRISPR/Cas9 has been used to make targeted mutations and insertions
·         Technical challenges and practical considerations

Register today and don’t miss out on this opportunity to learn from a pioneer in this new revolutionary technology.

________________________________
Shannon Byers, MS, MBA
Reproductive Sciences R&D
The Jackson Laboratory (box 26)
600 Main Street
Bar Harbor ME 04609
1.207.288.6726

No comments:

Post a Comment